<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Persistence of beta agonist efficacy over time</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Persistence of beta agonist efficacy over time</h1>
<div class="graphic"><div class="figure"><div class="ttl">Persistence of beta agonist efficacy over time</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Mean FEV1 as a percentage of the predicted value on the first and last days of treatment in patients with asthma. Therapy consisted of salmeterol (40 µg twice daily), albuterol (180 µg four times a day), or placebo. Both beta agonists increased the FEV1, but the effect of a single dose lasted longer with salmeterol. The beneficial effect of both agents persisted at twelve weeks.</div><div class="graphic_footnotes">FEV1: forced expiratory volume in one second.</div><div class="graphic_reference">Redrawn from Pearlman DS, Chervinsky P, LaForce C, et al, N Engl J Med 1992; 327:1420.</div><div id="graphicVersion">Graphic 78242 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
